Allspring Global Investments Holdings, LLC Repligen Corp Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Repligen Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 457,065 shares of RGEN stock, worth $67.2 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
457,065
Previous 254,054
79.91%
Holding current value
$67.2 Million
Previous $37.8 Million
74.01%
% of portfolio
0.11%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.11 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.05 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$751 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$249 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$227 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.16B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....